amrinone has been researched along with Arterial Obstructive Diseases in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nonaka, A | 1 |
| Kashimoto, S | 1 |
| Matsukawa, T | 1 |
| Kumazawa, T | 1 |
1 trial available for amrinone and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Effects of amrinon and prostaglandin E1 on intraoperative central and peripheral temperatures during peripheral arterial surgery].
Topics: Aged; Alprostadil; Amrinone; Anesthesia, Epidural; Anesthesia, General; Arterial Occlusive Diseases; | 1996 |